Shree Ganesh Biotech Share Price: Shree Ganesh Biotech India Limited is a publicly listed company that has consistently performed well on the stock exchanges.
Its steady growth trajectory has resulted in a reasonable stock valuation, reflecting investor confidence in its operating strategies and market position.
The company has successfully met its share price targets in the past months of this year, reflecting a strong operating performance. Given this trend, it is anticipated that the company’s 2025 share price targets will be easily achieved.
This optimistic outlook suggests continued growth and favourable market conditions for Shree Ganesh Biotech in the upcoming year.
Shree Ganesh Biotech (India) Company Overview
| Company Name | Shree Ganesh Biotech (India) Ltd. |
| Founded | 1982 |
| Headquarters | India |
| Industry | Agricultural |
| Chairman | Aman Pravinkumar Patel |
| Stock Exchange Listing | BSE |
| Official Website | shreeganeshbiotech.club |
Shree Ganesh Biotech (India) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Cap | ₹44.65 Cr. |
| ROE | 0.99% |
| ROCE | 1.36% |
| P/E | 0.7 |
| P/B | 2.98 |
| Div. Yield | 0% |
| Book Value | ₹1.59 |
| Face Value | ₹1 |
| EPS (TTM) | ₹0.03 |
| 52 Week High | ₹1.89 |
| 52 Week Low | ₹0.94 |
Also Read: ITI Share Price Target
Shree Ganesh Biotech (India) Financials
Income Statement
| (INR) | 2024 | Y/Y Change |
|---|---|---|
| Revenue | 202.78M | -67.53% |
| Operating expense | 4.47M | -33.83% |
| Net income | 6.21M | -69.55% |
| Net profit margin | 3.06 | -6.13% |
| Earnings per share | — | — |
| EBITDA | -2.00M | -109.32% |
| Effective tax rate | 27.39% | — |
Balance Sheet
| (INR) | 2024 | Y/Y Change |
|---|---|---|
| Cash and short-term investments | 4.28M | -10.85% |
| Total assets | 736.22M | -7.42% |
| Total liabilities | 106.44M | -37.99% |
| Total equity | 629.78M | — |
| Shares outstanding | 398.62M | — |
| Price to book | 0.70 | — |
| Return on assets | -0.16% | — |
| Return on capital | -0.20% | — |
Cash Flow
| (INR) | 2024 | Y/Y Change |
|---|---|---|
| Net income | 6.21M | -69.55% |
| Cash from operations | 101.58M | -3.63% |
| Cash from investing | -102.10M | -1.14% |
| Cash from financing | — | — |
| Net change in cash | -521.00K | -111.68% |
| Free cash flow | 94.11M | -4.40% |
Also Read: Raymond Share Price Target
Shree Ganesh Biotech Share Price Target From 2024 to 2030
| Year | Target Price |
|---|---|
| Shree Ganesh Biotech Share Price Target 2024 | ₹1.50 |
| Shree Ganesh Biotech Share Price Target​ 2025 | ₹2.20 |
| Shree Ganesh Biotech Share Price Target 2026 | ₹2.60 |
| Shree Ganesh Biotech Share Price Target 2027 | ₹3.00 |
| Shree Ganesh Biotech Share Price Target 2028 | ₹3.60 |
| Shree Ganesh Biotech Share Price Target 2029 | ₹4.00 |
| Shree Ganesh Biotech Share Price Target 2030 | ₹4.70 |
Shree Ganesh Biotech (India) Shareholding Pattern
- Retail & Other: 98.58%
- Promoters: —
- Foreign Institutions: 1.42%
- Mutual Funds: —
- Other Domestic Institutions: —
Also Read: Greaves Cotton Share Price Target
Shree Ganesh Biotech (India) Competitors/Peer Companies
- Biocon
- Advanced Enzyme
- Panacea Biotec
- Remus Pharmaceuticals
- Titan Biotech
- Vivo Bio Tech
Also Read: Steel Exchange Share Price Target
To connect with us, click on any of the given social media buttons.
FAQs
-
What is the Shree Ganesh Biotech Ltd Share Price Prediction 2025?
2.20 INR.
-
What is the Shree Ganesh Biotech Ltd Share Price Prediction 2026?
2.60 INR.
-
What is the Shree Ganesh Biotech Ltd Share Price Prediction 2027?
3.00 INR.
-
What is the Shree Ganesh Biotech Ltd Share Price Prediction 2029?
4.00 INR.
-
What is the Shree Ganesh Biotech Ltd Share Price Prediction 2030?
4.70 INR.
We have more than 7 years of experience in the stock market and analysis, and we are dedicated to delivering accurate, real-time market updates and insightful analysis. With a sharp eye on the Indian and global stock markets, we simplify complex financial data and trends to help investors make informed decisions.
Disclaimer: All the information provided in this article is for educational purposes only. We are not a SEBI registered firm. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
